- $2.92bn
 - $3.97bn
 - $2.38bn
 
- 88
 - 61
 - 57
 - 79
 
Annual income statement for ICU Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 1,271 | 1,316 | 2,280 | 2,259 | 2,382 | 
| Cost of Revenue | |||||
| Gross Profit | 461 | 491 | 698 | 740 | 825 | 
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,173 | 1,193 | 2,323 | 2,236 | 2,339 | 
| Operating Profit | 98.2 | 123 | -42.9 | 22.8 | 43 | 
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 97.5 | 123 | -114 | -78.3 | -66 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | 86.9 | 103 | -74.3 | -29.7 | -118 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | 86.9 | 103 | -74.3 | -29.7 | -118 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 86.9 | 103 | -74.3 | -29.7 | -118 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.08 | 5.5 | -1.1 | -0.114 | -3.19 |